Artikelen door HollandBIO

,

Positieve evaluatie Innovatiekrediet: regeling met 5 jaar verlengd

Afgelopen maanden liet het ministerie van Economische Zaken en Klimaat een aantal financieringsinstrumenten evalueren. Uit de evaluatie van onder andere het Innovatiekrediet, de VroegeFaseFinanciering en de Seed Capital-regeling blijkt dat sinds de start ongeveer duizend ondernemingen zijn geholpen. Staatssecretaris Mona Keijzer concludeert dat de regelingen ondernemers verder helpt en heeft besloten de regelingen met nog […]

ProteoNic Licenses Protein Production Technology to Eli Lilly

ProteoNic Biotechnology has licensed its 2G UNic™ technology for boosting recombinant protein production to Eli Lilly and Company. Under the agreement, Lilly gains non-exclusive commercial rights for application of the technology to the development of proprietary products. Financial details of the agreement were not disclosed. ProteoNic’s mammalian protein expression technology is designed to improve recombinant […]

André van de Sande ambassador and advisor of Pivot Park

André van de Sande has recently been appointed as ambassador and advisor to the Pivot Park in Oss. Together with the Pivot Park organization, Van de Sande is committed to creating opportunities for further growth of the campus. Activities that are part of the ambassadorship are the further increase of the park’s reputation as a […]

,

VITAL European Project Kicks Off

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched. VITAL will address – in a public-private consortium – the challenges of infections in the elderly and the potential of infection prevention by vaccination. Within the VITAL project, which will run from 2019-2023, University Medical Center (UMC) Utrecht will be […]

,

Ncardia Launches iPSC-Based Phenotypic Screening Service

Ncardia, a leading provider of human iPSC-derived cell-based assays and services for drug discovery and development, announced the launch of their DiscoverHIT drug screening platform. The new service enables researchers to access human disease-relevant biology earlier in the drug discovery process with the goal of bringing better medicines to patients faster. The DiscoverHIT Platform is […]

SMS-oncology reports strong growth in 2018, appointment of COO and future plans

SMS-oncology, a full-service contract research organization (CRO) solely dedicated to oncology drug development, today reports a continuous strong company growth in 2018. The growth comprises an increase in both revenue and employment base. To accommodate future growth, SMS-oncology strengthened its management team by promoting Ms. Eveline Verheijen to Chief Operating Officer (COO) per January 2019. […]

MSD Receives Breakthrough Therapy Designation from FDA for Vaccine

MSD  announced that V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of invasive pneumococcal disease (IPD) caused by the vaccine serotypes in pediatric patients 6 weeks to 18 years of age. V114 is also under development for the prevention […]

,

HollandBIO Year Event viert biotech innovatie

Afgelopen donderdag vierde HollandBIO samen leden en relaties haar eerste lustrum tijdens het Year Event in hartje Amsterdam. Hét leukste event van de Nederlandse biotech sector stond wederom bol van innovatie, inspirerend ondernemerschap en een gezonde dosis humor. De openingsvideo maakte in een klap duidelijk hoe de life sciences sector vandaag al bijdraagt aan een […]